|
TSEN15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.735400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.416600E-01 |
| Normal-vs-Stage2 |
6.273000E-01 |
| Normal-vs-Stage3 |
2.217500E-02 |
| Normal-vs-Stage4 |
4.419000E-01 |
| Stage1-vs-Stage2 |
9.846400E-01 |
| Stage1-vs-Stage3 |
1.172220E-02 |
| Stage1-vs-Stage4 |
3.660800E-01 |
| Stage2-vs-Stage3 |
1.619970E-02 |
| Stage2-vs-Stage4 |
3.717600E-01 |
| Stage3-vs-Stage4 |
5.850800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.060400E-01 |
| Normal-vs-AfricanAmerican |
7.378400E-01 |
| Normal-vs-Asian |
2.663000E-01 |
| Caucasian-vs-AfricanAmerican |
7.164400E-01 |
| Caucasian-vs-Asian |
7.283600E-01 |
| AfricanAmerican-vs-Asian |
5.623400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.850000E-01 |
| Normal-vs-Female |
2.199600E-02 |
| Male-vs-Female |
1.274250E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.320800E-01 |
| Normal-vs-Extreme_Weight |
9.624400E-01 |
| Normal-vs-Obese |
3.439800E-01 |
| Normal-vs-Extreme_Obese |
1.729220E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.149000E-01 |
| Normal_Weight-vs-Obese |
7.686400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.465000E-01 |
| Extreme_Weight-vs-Obese |
3.336600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.333400E-01 |
| Obese-vs-Extreme_Obese |
2.533200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.309700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.607200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.405600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.621600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.333640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.082400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.025900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.429200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.071990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.243560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.078000E-01 |
| Normal-VS-Type2 PRCC |
9.549800E-01 |
| Normal-VS-KIRP CIMP |
7.339800E-02 |
| Normal-VS-Unclassified PRCC |
5.464200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.209400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.710400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.380200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.480200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.866400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.487500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.422200E-01 |
| Normal-vs-N1 |
1.665980E-02 |
| Normal-vs-N2 |
7.953000E-01 |
| N0-vs-N1 |
8.519800E-03 |
| N0-vs-N2 |
5.000400E-01 |
| N1-vs-N2 |
3.936800E-01 |
|
|
